Podbit · The Peter Attia Drive
BPC-157 fails every test: no clear mechanism, no human RCTs after 30 years, unknown pharmacokinetics, and biologically plausible cancer concerns via VEGF and nitric oxide pathways. The scientist who discovered it has refused to publish the screening method. That's not a drug — it's a story.
Where this was said
At 14:15 · chapter starts 14:00
Peter applies his framework to BPC-157 — the poster child, he says, for everything that should make you skeptical of a peptide. On mechanism: the alleged parent protein has never been fully characterized, and the discoverer has refused to publish the screening method used to identify the compound, saying 'if you have your own child, you want it to be yours forever.' That's not missing data; that's deliberately withheld data — the scientific equivalent of 'trust me, bro.' Several mechanisms involving VEGF and nitric oxide have been proposed but none established in humans, and the primary receptor or target remains unknown. On human evidence: over 80% of the published literature comes from a single academic group with IP and commercial interests in the molecule, and independent replication is astonishingly thin. [1] — Peter Attia "BPC-157 fails every test: no clear mechanism, no human RCTs after 30 years, unknown pharmacokinetics, and biologically plausible cancer con…" 14:15 After approximately three decades of claims, there are no published peer-reviewed human RCTs. On safety and pharmacokinetics: human bioavailability is unknown, dosing protocols are guesses, and long-term risks have not been adequately studied. The risk-benefit calculation is also concerning: if BPC-157 truly stimulates VEGF and nitric oxide pathways as proponents claim, those are exactly the pathways that potentiate tumor biology. The conclusion: BPC-157 belongs firmly in Bucket 1.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Despite approximately 30 years of promotion and dozens of claimed benefits, there are no published peer-reviewed human randomized controlled trials demonstrating BPC-157 accelerates healing.
If BPC-157 meaningfully stimulates VEGF and nitric oxide pathways as proponents claim, those same pathways also potentiate tumor biology — a risk proponents fail to take seriously.
AI nailed Andrew Huberman's vertigo-vs-low-blood-pressure diagnosis because that pattern has been reported millions of times. But every patient's liver is different and data on liver surgeries is scarce worldwide — making solo robot surgery dangerous. The rule is simple: data abundance means AI can help; data scarcity means keep the human in the loop.
Fei-Fei Li's father had liver surgery performed by a da Vinci robot guided by a surgeon. The result: 10 times less blood loss than a typical procedure. This isn't replacement — it's the gold standard of human-machine collaboration, where the human's judgment and the robot's precision combine.
US drug overdose deaths fell from 110,000 to roughly 70,000 — the biggest CDC-recorded single-year drop ever. Men's rates fell 27% in one year, and the steepest decline of all was among 15–24-year-olds, down 37%. The crisis narrative around young men needs to make room for signs of genuine progress.
Kessler thought his grief expertise would protect him. It didn't. When his son David died unexpectedly, he found himself on the floor — and eventually realized that acceptance alone wasn't enough. That unmet need became the sixth stage: finding meaning.
Grief isn't just death — it's any unwanted change. Kessler lectured at Coca-Cola and General Mills not because they had lots of funerals, but because change management is grief management. People who grieve well live well.
Witnessing someone's grief isn't just emotional support — it's an essential act of healing. Kessler argues grief is a severance and connection heals it. But real witnessing has two steps: seeing the pain AND affirming the person's capacity to recover.
Avoiding grief isn't free — it's exhausting. Kessler's beach ball metaphor nails it: pushing a small balloon down is easy, but holding a massive beach ball underwater takes constant, draining energy. Unattended feelings don't disappear; they just consume you.
Most people try to control their environment to avoid triggers. Kessler flips this entirely: triggers aren't problems to manage around — they're a detailed map to your pain and your healing. Every trigger points directly to what needs attention.
Running from pain doesn't leave it behind — it accelerates the chase. Whatever we run from pursues us, and whatever we face transforms us. Both Kessler and Lewis Howes testify to knowing both roads firsthand.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.